The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes

Limbachia, Vaishali, Nunney, Ian, Page, Daniel J., Barton, Hannah A., Patel, Leena K., Thomason, Georgia N., Green, Stephan L., Lewis, Kieran F. J. and Dhatariya, Ketan (2024) The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes. Clinical Therapeutics, 46 (2). e59-e63. ISSN 0149-2918

Preview

PDF (Limbachia_etal_2024_ClinicalTherapeutics) - Published Version Available under License Creative Commons Attribution. Download (941kB) | Preview

Abstract

Purpose: This study investigated: (1) the type of corticosteroid associated with the greatest degree of hyperglycemia, assessed using bedside capillary blood glucose monitoring, in hospitalized patients; and (2) the pattern of hyperglycemia throughout the day with the use of each type of corticosteroid. Methods: This single-center, retrospective study used data from 964 adult inpatients receiving oral or IV corticosteroids. Data on capillary blood glucose concentrations and time taken over 7 days were collected. A mixed model for repeated measures was applied to investigate changes in glucose concentration over time with the use of four different corticosteroids. An autoregressive covariance structure was used to model correlations between repeated measurements. Findings: Across all 7 days, the mean blood glucose concentration was greater with dexamethasone compared to that with hydrocortisone (mean difference, 16.6 mg/dL [95% CI, 8.1–24.8] [0.92 mmol/L (95% CI, 0.45–1.38)]) or prednisolone (mean difference, 20.0 mg/dL [95% CI, 14.2–25.7] [1.11 mmol/L (95% CI, 0.79–1.43)]). The mean blood glucose concentration was greater with methylprednisolone compared to that with hydrocortisone (mean difference, 23.9 mg/dL [95% CI, 11.3–36.4] [1.33 mmol/L (95% CI, 0.63–2.02)]), and with methylprednisolone versus prednisolone (mean difference, 27.4 mg/dL [95% CI, 16.4–38.3] [1.52 mmol/L (95% CI, 0.91–2.13)]). There were no significant differences in the patterns of hyperglycemia at six time points of the day with each type of corticosteroid. Implications: Treatment with oral or IV dexamethasone or methylprednisolone was associated with greater hyperglycemia in comparison to prednisolone and hydrocortisone. More vigorous monitoring and intervention, when necessary, are suggested in adult inpatients receiving corticosteroids, in particular dexamethasone and methylprednisolone.

Item Type:	Article
Uncontrolled Keywords:	sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	LivePure Connector
Date Deposited:	20 Dec 2023 02:58
Last Modified:	04 Mar 2024 18:23
URI:	https://ueaeprints.uea.ac.uk/id/eprint/94016
DOI:	10.1016/j.clinthera.2023.11.013

Downloads

Actions (login required)

View Item